BioFocus And University Of Bristol Enter Drug Discovery Collaboration In Chronic Pain

Life Science Leader (Jul 26 2010)

1. BioFocus and the University of Bristol today announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain). BioFocus will provide hit-to-lead and lead optimization services for a Wellcome Trust funded program at the University of Bristol. Total contract value for BioFocus could exceed €3.3 million in research fees over two years. This work is supported by a Seeding Drug Discovery Award from the Wellcome Trust, to a team of researchers led by David Wynick, Professor of Molecular Medicine at the University of Bristol. The project aims to develop a new ... (Read Full Article)

   Bookmark or Share this article

Login to comment.